We have previously identified that Wnt7a is lost in non-small cell lung cancers (NSCLC) [5], [6], and restoration of Wnt7a signaling in NSCLC cell lines leads to reversal of transformed phenotype [6], unveiling Wnt7a signaling as a novel tumor suppressive pathway in lung cancer. This evidence concerns the gene WNT7A and neoplasm.